Reduced expression of central innate defense molecules in pancreatic biopsies from subjects with Type 1 diabetes
Aims/Hypothesis Defensins play a crucial role in the innate immune system's first defense against microbial threats. However, little is known about the defensin system in the pancreas, especially in relation to Type 1 diabetes. We explore the expression of defensins in different disease stages...
Saved in:
Published in | Acta diabetologica Vol. 61; no. 9; pp. 1117 - 1127 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Milan
Springer Milan
01.09.2024
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 1432-5233 0940-5429 1432-5233 |
DOI | 10.1007/s00592-024-02286-1 |
Cover
Summary: | Aims/Hypothesis
Defensins play a crucial role in the innate immune system's first defense against microbial threats. However, little is known about the defensin system in the pancreas, especially in relation to Type 1 diabetes. We explore the expression of defensins in different disease stages of Type 1 diabetes and correlated obtained findings to the degree of inflammation, providing new insights into the disease and the innate immune system.
Material and methods
Pancreases from non-diabetic human organ donors of different age groups and donors with Type 1 diabetes with different disease duration were examined. Sections from head, body and tail of the pancreas were stained for eight different defensins and for immune cells; CD3+, CD45+, CD68+ and NES+ (granulocytes).
Results
In non-diabetic adult controls the level of expression for defensins Beta-1,Alpha-1, Cathelicidin and REG3A correlated with the level of inflammation. In contrast, individuals with Type 1 diabetes exhibit a reduction or absence of several central defensins regardless of the level of inflammation in their pancreas. The expression of Cathelicidin is present in neutrophils and macrophages but not in T-cells in subjects with Type 1 diabetes.
Conclusions
Obtained findings suggest a pancreatic dysfunction in the innate immune system and the bridging to the adaptive system in Type 1 diabetes. Further studies on the role of the local innate immune system in Type 1 diabetes is needed. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Managed by Piero Marchetti. |
ISSN: | 1432-5233 0940-5429 1432-5233 |
DOI: | 10.1007/s00592-024-02286-1 |